Items Tagged ‘panobinostat’

April 22nd, 2015

Panobinostat

By

Class: Biological Therapy Generic Name: Panobinostat Trade Name: Farydak® For which conditions is this drug approved? Farydak® is approved for use, in combination with Velcade® (bortezomib) and dexamethasone, in people with multiple myeloma after they’ve had at least two other types of treatment. What is the mechanism of action? Farydak is an agent known as a […]

View full entry

Tags: Biological Therapy, Drug Dictionary, farydak, Multiple Myeloma, P, panobinostat


April 22nd, 2015

Farydak®

By

Class: Biological Therapy Generic Name: Panobinostat Trade Name: Farydak® For which conditions is this drug approved? Farydak® is approved for use, in combination with Velcade® (bortezomib) and dexamethasone, in people with multiple myeloma after they’ve had at least two other types of treatment. What is the mechanism of action? Farydak is an agent known as a […]

View full entry

Tags: Biological Therapy, Drug Dictionary, F, farydak, Multiple Myeloma, panobinostat


February 25th, 2015

Farydak® Approval Provides Another Treatment Option for Patients With Multiple Myeloma

By

Novartis announced today that the US Food and Drug Administration (FDA) has approved Farydak® (panobinostat) in combination with Velcade® and dexamethasone for the treatment of patients with multiple myeloma who have received at least two prior regimens, including Velcade® and an immunomodulatory (IMiD) agent. The FDA approval was partially based on the results of the […]

View full entry

Tags: bortezomib, farydak, Multiple Myeloma, News, panobinostat, Recurrent Multiple Myeloma, velcade


November 5th, 2014

Adding Pan-Deacetylase Inhibitor Panobinostat to Velcade and Dexamethasone Improves Progression-Free Survival in Relapsed Myeloma

By

In the phase III PANORAMA1 trial reported in The Lancet Oncology San-Miguel and colleagues found that adding the pan-deacetylase inhibitor panobinostat to Velcade ® (bortezomib) and dexamethasone improved progression-free survival in patients with relapsed or relapsed and refractory multiple myeloma. Multiple myeloma is a cancer of plasma cells, which are a special type of white […]

View full entry

Tags: Multiple Myeloma, News, panobinostat, Recurrent Multiple Myeloma, refractory